Etizolam and benzodiazepine induced blepharospasm [2]

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 3, 2004, Pages 506-507

  Wakakura, M ^a   Tsubouchi, T ^a   Inouye, J ^a  

^a Nishikasai Inouye Eye Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; ETIZOLAM; NEUROLEPTIC AGENT;

BLEPHAROSPASM; DRUG INDICATION; HUMAN; INCIDENCE; LETTER; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; SEX RATIO;

EID: 1542721754     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2003.024745     Document Type: Letter

References (5)

1. Weiner WJ, Nausieda PA, Glantz RH. Meige syndrome (Blepharospasm or blepharospasm-oromandibular dystonia) after long-term neuroleptic therapy. Neurology 1981;31:1555-6.
2. Jankovic J, Ford J. Blepharospasm and orofacial-caervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol 1983;13:402-11.
3. Mauriello JA, Carbonaro P, Dhillon S, et al. Drug-induced facial dyskinesias. A study of 238 patients. J Neuro-ophthalmology 1998;18:153-7.
4. Baker RS, Andersen AH, Morecraft RJ, et al. A functional magnetic resonance imaging in patients with benign essential blepharospasm. J Neuro-ophthalmology 2003;23:11-15.
5. Klein RL, Harris RA. Regulation of GABAA receptor structure and function by chronic drug treatments in vivo and with stably transfected cells. Jpn J Pharmacology 1996;70:1-15.